Lumonus inks joint venture with NY cancer centre to scale AI oncology
Lumonus, a GenesisCare spinout chaired by Merrick Howes, is partnering with a New York cancer centre to co-develop automated radiotherapy planning tools.
Company
Every investor coverage indicates participated in a round Anchorage Capital Group raised.
Companies Anchorage Capital Group acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Merrick Howes | Boss (former) | Brandon Capital portfolio (1 Apr 2026), Brandon Capital portfolio (23 Mar 2021) |
Stories naming Anchorage Capital Group. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Lumonus, a GenesisCare spinout chaired by Merrick Howes, is partnering with a New York cancer centre to co-develop automated radiotherapy planning tools.
Fintech firm GBST has hired Kirsty Worgan as its global Chief Commercial Officer, returning her to the company where she previously led business development, with responsibility for commercial growth and mergers and acquisitions.
Index of the venture firm's portfolio updates: financing rounds for AdvanCell and ENA Respiratory, grant awards via incubator programs, two closes of Fund Six, board hires, and Myricx Bio's completed sale to Novartis.
Also Brandon BioCatalyst portfolio·Brandon Capital portfolio·Uniseed·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon Capital portfolio·SmartCompany·AFR Technology·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·@AuManufacturing·finance.yahoo.com·enarespiratory.com·Mirage News·advancell.com.au·Forbes Australia·datapile.co·Dealroom·Forbes Australia·datapile.co·Biotech Dispatch·fundedstartupsdaily.com·fundedstartupsdaily.com